Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
letter
. 2012 Feb;18(2):342–343. doi: 10.3201/eid1802.111333

Dengue Surveillance among French Military in Africa

Franck de Laval 1,2,3, Sébastien Plumet 1,2,3, Fabrice Simon 1,2,3, Xavier Deparis 1,2,3, Isabelle Leparc-Goffart 1,2,3,
PMCID: PMC3311153  PMID: 22305127

To the Editor: In their recent article, Amarasinghe et al. (1) describe dengue virus distribution in Africa. Their data were based on published reports of dengue cases among local populations and travelers returning from Africa. To complement the description by Amarasinghe and colleagues of dengue serotypes found in Africa, we report results from dengue virologic testing during 1998–2010. The tests were performed at the Arbovirus National Reference Center (Tropical Medicine Institute of the Military Health Service, Marseille, France).

Each year, ≈14,000 French soldiers are stationed in dengue-endemic areas of Africa (mainly Cameroon, Central African Republic, Chad, Djibouti, Gabon, Côte d’Ivoire, Senegal, and Mayotte and Reunion islands), from which they travel throughout Africa. The population of soldiers is under constant epidemiologic surveillance. If symptoms of dengue fever develop in a soldier, a blood sample and a dengue-specific questionnaire from the patient are sent to the Tropical Medicine Institute of the Military Health Service. Virus culture and reverse transcription PCR, or both, were performed on early samples; otherwise, serologic testing was performed by using in-house assays (IgM antibody capture ELISA and direct IgG ELISA).

During the 12 years of surveillance, the laboratory received 2,423 samples from patients with suspected dengue within the French Armed Forces in Africa. Of these, 224 were probable acute dengue infections: 202 had positive IgM serologic results for dengue, and 22 were confirmed as dengue cases by RT-PCR or culture (Table). Serologic data may be confusing because of potential cross-reactions with other flavivirus antibodies (in particular in Chad with West Nile virus).

Table. Countries in Africa with evidence of dengue virus transmission among French Armed Forces, 1998–2010.

Country and year No. cases Testing method Infection status Dengue virus serotype
Cameroon, 2010 1 PCR Confirmed 1
Cape Verde, 2010 5 Culture Confirmed 3
Central African Republic, 1995 1 Serology Probable Unknown
Chad, 1998–2001, 2003, 2006, 2009–2010 28 Serology Probable Unknown
Comoros
2010 1 PCR, culture Confirmed 1
2010 2 PCR Confirmed 3
Côte d’Ivoire
1999 1 Culture Confirmed 1
2000, 2004–2007 11 Serology Probable Unknown
2010 1 PCR Confirmed 3
Djibouti
1998 4 Culture Confirmed 1
1998 24 Serology Probable Unknown
2000 2 Culture Confirmed 1
2000 4 Serology Probable Unknown
2001–2005 123 Serology Probable Unknown
2005 1 PCR Confirmed ND
2006 4 Serology Probable Unknown
2008 2 Serology Probable Unknown
Gabon
1998, 2006–2008 22 Serology Probable Unknown
2010 1 PCR Confirmed 1
Mayotte, 2009 1 Culture Confirmed 1
Senegal, 2009 1 PCR confirmed 3
Somalia, 1999 1 culture confirmed 2

Because of probable underreporting from the field, our reported number of confirmed dengue cases likely underestimates the actual number of cases among French troops stationed in Africa. Nonetheless, our data complement those reported by Amarasinghe et al. by demonstrating additional locations for circulation of serotype 1 (Cameroon, Djibouti, Gabon, Mayotte) and serotype 3 (Comoros). Military epidemiologic surveillance systems can detect dengue circulation where soldiers stay. Thus, these systems could serve to evaluate the risk for dengue infection in countries without local epidemiologic surveillance systems, thereby improving knowledge about dengue circulation in African countries.

Footnotes

Suggested citation for this article: de Laval F, Plumet S, Simon F, Deparis X, and Leparc-Goffart I. Dengue surveillance among French military in Africa [letter]. Emerg Infect Dis [serial on the Internet]. 2012 Feb [date cited]. http://dx.doi.org/10.3201/eid1802.111333

Reference


Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES